Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

By G. Musso, M. Cassader, F. Rosina, R. Gambino. Diabetologia, 2012

676 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Treatment of NAFLD with diet, physical activity and exercise. (2017, methodology): “This equivalence of diets is also supported by a small meta-analysis.(149) These findings indicate that the diet of choice should be the one which individuals are able to adhere to for years, as long as it is generally healthy and leads to weight reduction.”
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. (2013, background): “Several medications including vitamin E have recently been shown to be ineffective in preventing fibrosis [35], and while other pharmaceutical therapies, such as thiazoladinediones, have had some success in improving liver histology, they have undesirable side effects such as weight gain [36].”
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018, background): “at least 5% of body weight had improvement in hepatic steatosis, while ≥7% body weight reduction was associated with NAS improvement (135).”